Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Gilead Sciences, Inc. v. Watson Labs., Inc., 15-0289 (D. Del.) Apr. 1, 2015 Hon. Sue L. Robinson Letairis® (ambrisentan tablets) RE42,462
Coalition for Affordable Drugs II LLC v. Shire Inc., IPR2015-00988 (PTAB) Apr. 1, 2015 N/A Lialda® (mesalamine delayed-release tablets) 6,773,720
Elan Pharma International Ltd. v. Actavis Labs. UT, Inc., 15-0291 (D. Del.) Apr. 2, 2015 Hon. Leonard P. Stark Clindesse® (clindamycin phosphate vaginal cream) 6,899,890
Merck Sharp & Dohme Corp. v. Apotex Inc., 15-2384 (D.N.J.) Apr. 2, 2015 Hon. Peter G. Sheridan Nasonex® (mometasone furoate nasal spray) 6,127,353
Gilead Sciences, Inc. v. Watson Labs., Inc., 15-2350 (D. Del.) Apr. 3, 2015 Hon. Kevin McNulty Letairis® (ambrisentan tablets) RE42,462
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 15-2520 (D.N.J.) Apr. 6, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel Injection) 8,927,592
Sanofi-Aventis U.S. LLC v. BPI Labs, LLC, 15-2521 (D.N.J.) Apr. 6, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel Injection) 8,927,592
Sanofi-Aventis U.S. LLC v. Dr. Reddy’s Labs., Inc., 15-2522 (D.N.J.) Apr. 6, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel Injection) 8,927,592
Sanofi-Aventis U.S. LLC v. Glenmark Generics Inc., 15-2523 (D.N.J.) Apr. 6, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel Injection) 8,927,592
Coalition for Affordable Drugs III LLC v. Jazz Pharms., Inc., IPR2015-01018 (PTAB) Apr. 6, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,895,059
Supernus Pharms., Inc. v. Actavis Inc., 15-2499 (D.N.J.) Apr. 7, 2015 Hon. Renee Marie Bumb Oxtellar XR® (oxcarbazepine extended-release tablets) 8,821,930
Elan Pharma International Ltd. v. Actavis Labs. UT, Inc., 15-2528 (D.N.J.) Apr. 8, 2015 Hon. Jose L. Linares Clindesse® (clindamycin phosphate vaginal cream) 6,899,890
Janssen Products, L.P. v. Cipla Ltd., 15-2549 (D.N.J.) Apr. 9, 2015 Hon. William H. Walls Prezista® (darunavir tablets)
7,700,645
8,518,987
7,126,015
7,595,408
Lupin Ltd. v. Janssen Sciences Ireland UC, IPR2015-01030 (PTAB) Apr. 9, 2015 N/A Prezista® (darunavir tablets) 8,518,987
Teva Pharms. USA, Inc. v. Dr. Reddy’s Labs., Ltd., 15-0306 (D. Del.) Apr. 10, 2015 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection) 8,969,302
Janssen Products, L.P. v. Cipla Ltd., 15-0307 (D. Del.) Apr. 10, 2015 Hon. Sue L. Robinson Prezista® (darunavir tablets)
7,700,645
8,518,987
7,126,015
7,595,408
U.S. Dept. of Health and Human Services v. Cipla Ltd., 15-2571 (D.N.J.) Apr. 10, 2015 Hon. William H. Walls Prezista® (darunavir tablets)
7,470,506
8,597,876
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC., 15-2631 (D.N.J.) Apr. 13, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel Injection) 8,927,592
Mylan Pharms. Inc. v. Nissan Chemical Industries Ltd., IPR2015-01069 (PTAB) Apr. 18, 2015 N/A Livalo® (pitavastatin calcium tablets) 5,856,336
Shire Development LLC v. Amneal Pharms. LLC, 15-2865 (D.N.J.) Apr. 22, 2015 Hon. Joseph E. Irenas Lialda® (mesalamine delayed-release tablets) 6,773,720
Medicis Pharm. Corp. v. Taro Pharms. U.S.A., Inc., 15-2841 (D.N.J.) Apr. 22, 2015 Hon. Renee Marie Bumb Zyclara® (imiquimod 3.75% cream)
8,236,816
8,598,196
8,598,196
Coalition For Affordable Drugs V LLC v. Biogen IDEC International GmbH, IPR2015-01086 (PTAB) Apr. 22, 2015 N/A Tecfidera® (dimethyl fumarate delayed-release capsules) 8,759,393
Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01092 (PTAB) Apr. 22, 2015 N/A
Revlimid® (lenalidomide capsules)
Pomalyst® (pomalidomide capsules)
Thalomid® (thalidomide capsules)
6,045,501
Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0328 (D. Del.) Apr. 23, 2015 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system)

6,841,716 
8,231,906
Coalition For Affordable Drugs II LLC v. NPS Pharms., Inc., IPR2015-01093 (PTAB) Apr. 23, 2015 N/A Gattex Kit® (recombinant teduglutide subcutaneous powder) 7,056,886
Coalition For Affordable Drugs VI LLC v. Celgene, IPR2015-01096 (PTAB) Apr. 23, 2015 N/A Revlimid® (lenalidomide capsules) 6,315,720
Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01097 (PTAB) Apr. 23, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,754,131
Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01099 (PTAB) Apr. 23, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,669,290
Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01100 (PTAB) Apr. 23, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,927,606
Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01102 (PTAB) Apr. 23, 2015 N/A Pomalyst® (pomalidomide capsules) 6,315,720
Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01103 (PTAB) Apr. 23, 2015 N/A Thalomid® (thalidomide capsules) 6,315,720
Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01105 (PTAB) Apr. 23, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,871,813
Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0069 (N.D.W.V.) Apr. 24, 2015 Hon. Irene M. Keeley Minivelle® (estradiol transdermal system)
6,841,716
8,231,906
Apotex, Inc. v. Daiichi Sankyo, Inc., 15-3695 (N.D. Ill.) Apr. 27, 2015 Hon. Rebecca R. Pallmeyer Benicar® HCT (olmesartan medoxomil / hydrochlorothiazide tablets) 6,878,703
Eli Lilly and Co. v. Lupin Ltd., 15-0673 (S.D. Ind.) Apr. 27, 2015 Hon. Sarah Evans Barker Effient® (prasugrel hydrochloride tablets)
8,404,703
8,569,325
Par Pharm., Inc. v. Hyperion Therapeutics, Inc., IPR2015-01117 (PTAB) Apr. 29, 2015 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 8,642,012
Par Pharm., Inc. v. Hyperion Therapeutics, Inc., IPR2015-01127 (PTAB) Apr. 29, 2015 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 8,404,215
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-3051 (D.N.J.) Apr. 30, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450 
8,563,613
8,618,164
8,871,809
Sanofi-Aventis U.S. LLC v. Actavis LLC, 15-3107 (D.N.J.) May 1, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 8,927,592
Bausch & Lomb Inc. v. Micro Labs USA, Inc., 15-3113 (D.N.J.) May 1, 2015 Hon. Noel L. Hillman Bepreve® (bepotastine besilate ophthalmic solution) 8,877,168
Apotex Inc. v. Lupin Ltd., 15-0599 (E.D. Tex.) May 1, 2015 Hon. Robert W. Schroeder, III Paxil CR® (paroxetine hydrochloride controlled-release tablets) 7,229,640
Coalition For Affordable Drugs V LLC v. Biogen MA Inc., IPR2015-01136 (PTAB) May 1, 2015 N/A Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Apotex Inc. v. Lupin Ltd., 15-0357 (D. Del.) May 4, 2015 Hon. Leonard P. Stark Paxil CR® (paroxetine hydrochloride controlled-release tablets) 7,229,640
Vanda Pharms. Inc. v. Inventia Healthcare Pvt. Ltd., 15-0362 (D. Del.) May 5, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets) 8,586,610
Galderma Labs., L.P. v. Glenmark Generics Inc., USA, 15-1416 (N.D. Tex.) May 6, 2015 Hon. Barbara M. G. Lynn Epiduo® (adapalene /benzoyl peroxide gel)
8,071,644
8,080,537
8,129,362
8,445,543
8,809,305
Jazz Pharms., Inc. v. Amneal Pharms., LLC, 15-3217 (D.N.J.) May 7, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,952,062
Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01169 (PTAB) May 7, 2015 N/A Revlimid® (lenalidomide capsules) Pomalyst® (pomalidomide capsules) 5,635,517
Senju Pharm. Co., Ltd. v. Innopharma Licensing, Inc., 15-3240 (D.N.J.) May 8, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
Altaire Pharms., Inc. v. Paragon Biotek, Inc., PGR2015-00011 (PTAB) May 11, 2015 N/A Phenylephrine Hydrochloride (phenylephrine hydrochloride ophthalmic solution) 8,859,623
Duchesnay Inc. v. Mylan Pharms. Inc., 15-0385 (D. Del.) May 13, 2015 Hon. Sue L. Robinson Diclegis® (doxylamine succinate / pyridoxine hydrochloride delayed-release tablets) 6,340,695
Horizon Pharma, Inc. v. Actavis Labs. FL., Inc., 15-3322 (D.N.J.) May 13, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,852,636 
8,858,996
Horizon Pharma, Inc. v. Dr. Reddy’s Labs. Inc., 15-3324 (D.N.J.) May 13, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,852,636 
8,858,996
Horizon Pharma, Inc. v. Lupin Ltd., 15-3326 (D.N.J.) May 13, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,852,636 
8,858,996
Horizon Pharma, Inc. v. Mylan Pharms. Inc., 15-3327 (D.N.J.) May 13, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,852,636 
8,858,996
Merz Pharms., LLC v. Taro Pharms. U.S.A., Inc., 15-3720 (S.D.N.Y.) May 14, 2015 Hon. William H. Pauley, III Naftin® (naftifine hydrochloride gel) 8,778,365
Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-3367 (D.N.J.) May 15, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078 
8,252,838 
8,546,450 
8,563,613 
8,618,164 
8,871,809
Takeda GmbH v. Torrent Pharma Inc., 15-3375 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Micro Labs USA, Inc., 15-3376 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Zydus Pharms. (USA) Inc., 15-3377 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Strides Pharma, Inc., 15-3378 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Apotex Corp., 15-3379 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Prinston Pharm. Inc., 15-3380 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
5,712,298
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Breckenridge Pharm. Inc., 15-3382 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
5,712,298 
8,536,206 
8,604,064 
8,618,142
Takeda GmbH v. Citron Pharma LLC, 15-3383 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Mylan Pharms. Inc., 15-3384 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
5,712,298
8,536,206
8,604,064
8,618,142
Takeda GmbH v. Hetero USA Inc., 15-3385 (D.N.J.) May 15, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets)
8,536,206
8,618,142
8,618,142
Acorda Therapeutics, Inc. v. Sun Pharm. Indus. Ltd., 15-0391 (D. Del.) May 15, 2015 Hon. Leonard P. Stark Ampyra® (dalfampridine extended-release tablets)
8,007,826
8,354,437
8,440,703
8,663,685
Sanofi-Aventis U.S. LLC v. Onco Therapies Ltd., 15-3392 (D.N.J.) May 15, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 8,927,592
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-0393 (D. Del.) May 15, 2015 Hon. Gregory M. Sleet Quillivant® (methylphenidate hydrochloride extended-release oral suspension) 8,956,649
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-3399 (D.N.J.) May 15, 2015 Hon. Madeline C. Arleo Quillivant® (methylphenidate hydrochloride extended-release oral suspension) 8,956,649
Vanda Pharms. Inc. v. Inventia Healthcare Pvt. Ltd., 15-0059 (N.D.W.V.) May 15, 2015 Hon. Gina M. Groh Fanapt® (iloperidone tablets) 8,586,610
Akorn, Inc. v. Senju Pharm. Co., Ltd., IPR2015-01205 (PTAB) May 15, 2015 N/A Durezol® (difluprednate ophthalmic emulsion) 6,114,319
Cephalon, Inc. v. Apotex Inc., 15-0404 (D. Del.) May 19, 2015 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion)
8,445,524
8,436,190
8,609,863
8,791,270
8,669,279
8,883,836
8,895,756
Merck & CIE v. Lupin Ltd., 15-0407 (D. Del.) May 20, 2015 Hon. Richard G. Andrews Safyral® (drospirenone / 17α-ethinylestradiol / levomefolate calcium tablets) 6,441,168
Eli Lilly and Co. v. HEC Pharm USA, Inc., 15-0792 (S.D. Ind.) May 20, 2015 Hon. Jane Magnus-Stinson Effient® (prasugrel hydrochloride tablets)
8,404,703
8,569,325
Recro Technology LLC v. Actavis Labs. FL., Inc., 15-0413 (D. Del.) May 21, 2015 Hon. Gregory M. Sleet Zohydro® (hydrocodone bitartrate extended-release capsules)
6,228,398
6,902,742
Sanofi v. Lupin Atlantis Holdings S.A., 15-0415 (D. Del.) May 21, 2015 Hon. Richard G. Andrews Multaq® (dronedarone tablets)
8,318,800
8,410,167
Merck & CIE v. Lupin Ltd., 15-1472 (D. Md.) May 21, 2015 Hon. J. Frederick Motz Safyral® (drospirenone / 17α-ethinylestradiol / levomefolate calcium tablets) 6,441,168
Horizon Pharma Ireland Ltd. v. IGI Labs., Inc., 15-3508 (D.N.J.) May 21, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Coalition for Affordable Drugs VII LLC v. Pozen Inc., IPR2015-01241 (PTAB) May 21, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 6,926,907
Kowa Co., Ltd. v. Lupin Ltd, 15-3935 (S.D.N.Y.) May 21, 2015 Hon. Paul A. Crotty Livalo® (pitavastatin calcium tablets) 8,557,993
Kowa Co., Ltd. v. Lupin Ltd, 15-1495 (D. Md.) May 22, 2015 Hon. George Jarrod Hazel Livalo® (pitavastatin calcium tablets) 8,557,993
Cipla Ltd. v. Sunovion Pharms. Inc., 15-0424 (D. Del.) May 26, 2015 Hon. Leonard P. Stark Xopenex HFA® (levalbuterol tartrate) RE43,984
Janssen Pharms., Inc. v. Vintage Pharms. LLC, 15-3542 (D.N.J.) May 26, 2015 Hon. Stanley R. Chesler Ortho Tri-cyclen® Lo (norgestimate / ethinyl estradiol tablets) 6,214,815
Duchesnay Inc. v. Mylan Pharms. Inc., 15-0092 (N.D.W.V.) May 27, 2015 Hon. Irene M. Keeley Diclegis® (doxylamine succinate / pyridoxine hydrochloride delayed-release tablets) 6,340,695
Takeda GmbH v. Mylan Pharms. Inc., 15-0093 (N.D.W.V.) May 27, 2015 Hon. Irene M. Keeley Daliresp® (roflumilast tablets)
5,712,298
8,536,206
8,604,064
8,618,142
Janssen Pharms., Inc. v. Vintage Pharms. LLC, 15-0429 (D. Del.) May 28, 2015 Hon. Richard G. Andrews Ortho Tri-cyclen® Lo (norgestimate / ethinyl estradiol tablets) 6,214,815
Forest Labs., LLC v. Amneal Pharms., LLC, 15-0430 (D. Del.) May 28, 2015 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 5,763,476
Warner Chilcott Co., LLC v. Amneal Pharms. LLC, 15-3590 (D.N.J.) May 28, 2015 Hon. Mary L. Cooper Minastrin® 24 Fe (ethinyl estradiol / norethindrone acetate / ferrous fumarate tablets) 6,667,050
Novartis Pharms. Corp. v. Apotex, Inc., 15-3634 (D.N.J.) May 29, 2015 Hon. Susan D. Wigenton Zometa® (zoledronic acid concentrate for intravenous infusion) 8,324,189
Fresenius Kabi USA, LLC v. Fera Pharms., LLC, 15-3654 (D.N.J.) May 29, 2015 Hon. Claire C. Cecchi Levothyroxine Sodium (levothyroxine sodium powder for injection) 9,006,289
Fresenius Kabi USA, LLC v. Innopharma Licensing, LLC, 15-3655 (D.N.J.) May 29, 2015 Hon. Claire C. Cecchi Levothyroxine Sodium (levothyroxine sodium powder for injection) 9,006,289
Mylan Pharms., Inc. v. Janssen Pharms., Inc., 15-2990 (E.D. Pa.) May 29, 2015 Hon. Mark A. Kearney Concerta® (methylphenidate hydrochloride extended-release tablets) 8,629,179
Jazz Pharms., Inc. v. Roxane Labs., Inc., 15-3684 (D.N.J.) June 1, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,952,062
Takeda Pharm. Co. Ltd. v. Actavis Labs. FL, Inc., 15-0451 (D. Del.) June 3, 2015 Hon. Richard G. Andrews Contrave® (naltrexone hydrochloride / bupropion hydrochloride extended-release tablets)
7,375,111
7,462,626
8,088,786
8,318,788
8,722,085
8,815,889
8,916,195
Teijin Ltd. v. Macleods Pharms. Ltd., 15-0454 (D. Del.) June 4, 2015 Hon. Sue L. Robinson Uloric® (febuxostat tablets) 7,361,676
Apotex Corp. v. Allergan, Inc., IPR2015-01278 (PTAB) June 4, 2015 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,633,162
Apotex Corp. v. Allergan, Inc., IPR2015-01282 (PTAB) June 4, 2015 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,629,111
Apotex Corp. v. Allergan, Inc., IPR2015-01283 (PTAB) June 4, 2015 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,685,930
Apotex Corp. v. Allergan, Inc., IPR2015-01284 (PTAB) June 4, 2015 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,648,048
Apotex Corp. v. Allergan, Inc., IPR2015-01286 (PTAB) June 4, 2015 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,642,556
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2015-01340 (PTAB) June 4, 2015 N/A
Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze® XR (metformin hydrochloride / 
saxagliptin hydrochloride extended-release tablets)
RE44,186
Bayer Pharma AG v. Macleods Pharms. Ltd., 15-0464 (D. Del.) June 5, 2015 Hon. Gregory M. Sleet Staxyn® (vardenafil hydrochloride tablets) 8,613,950
Mallinckrodt LLC v. Watson Labs., Inc.-Florida, 15-3800 (D.N.J.) June 5, 2015 Hon. Katharine S. Hayden Xartemis® XR (acetaminophen / oxycodone hydrochloride extended-release tablets)
8,597,681
8,658,631
8,741,885
8,980,319
8,992,975
7,976,870
8,668,929
Bausch & Lomb Inc. v. Apotex Inc., 15-3879 (D.N.J.) June 5, 2015 Hon. Noel L. Hillman Bepreve® (bepotastine besilate ophthalmic solution)
8,784,789
8,877,168
Coalition for Affordable Drugs VII LLC v. Pozen Inc., IPR2015-01344 (PTAB) June 5, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 8,858,996
Actavis Labs. UT, Inc. v. UCB, Inc., 15-1001 (E.D. Tex.) June 8, 2015 Hon. Rodney Gilstrap Neupro® (rotigotine transdermal system) 7,921,999
Fresenius Kabi USA, LLC v. Par Sterile Products, LLC, 15-3852 (D.N.J.) June 9, 2015 Hon. Claire C. Cecchi Levothyroxine Sodium (levothyroxine sodium powder for injection) 9,006,289
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-0474 (D. Del.) June 10, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
9,006,224
8,410,131
Novartis Pharms. Corp. v. Par Pharm., Inc., 15-0475 (D. Del.) June 10, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 9,006,224
Reckitt Benckiser Pharms. Inc. v. Alvogen Pine Brook, Inc., 15-0477 (D. Del.) June 10, 2015 Hon. Richard G. Andrews Suboxone (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
8,900,497
8,906,277
Alcon Research, Ltd. v. Akorn Inc., 15-0479 (D. Del.) June 11, 2015 Hon. Sue L. Robinson Travatan Z® (travoprost ophthalmic solution)
8,268,299
8,323,630
8,388,941
Par Pharm., Inc. v. Breckenridge Pharm., Inc., 15-0486 (D. Del.) June 12, 2015 Hon. Sue L. Robinson Megace® ES (megestrol acetate oral suspension) 9,040,088
Meda Pharms. Inc. v. Roxane Labs., Inc., 15-0510 (D. Del.) June 17, 2015 Hon. Gregory M. Sleet Astepro® (azelastine hydrochloride nasal spray)
8,071,073
8,518,919
Hetero Labs Ltd. Unit V v. Pharmacia & Upjohn Co. LLC, 15-5396 (N.D. Ill.) June 18, 2015 Hon. Matthew F. Kennelly Zyvox® (linezolid tablets)
6,514,529
6,559,305
Ferring B.V. v. Actavis, Inc., 15-4222 (D.N.J.) June 23, 2015 Hon. Katharine S. Hayden Lysteda® (tranexamic acid tablets) 9,060,939
Cephalon, Inc. v. Fresenius Kabi USA, LLC, 15-0536 (D. Del.) June 24, 2015 Hon. Leonard P. Stark Treanda® (bendamustine hydrochloride for infusion) 8,344,006
Pharmacosmos A/S v. Luitpold Pharms., Inc., IPR2015-01490 (PTAB) June 24, 2015 N/A Injectafer® (ferric carboxymaltose for injection) 7,754,702
Pharmacosmos A/S v. Luitpold Pharms., Inc., IPR2015-01495 (PTAB) June 24, 2015 N/A Injectafer® (ferric carboxymaltose for injection) 8,895,612
Millennium Pharms., Inc. v. Dr. Reddy’s Labs., Ltd., 15-0539 (D. Del.) June 25, 2015 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
Novartis Pharms. Corp. v. Aurobindo Pharma Ltd., 15-4427 (D.N.J.) June 25, 2015 Hon. Susan D. Wigenton Zometa® (zoledronic acid concentrate for intravenous infusion) 8,324,189
Reckitt Benckiser LLC v. Dr. Reddy’s Labs., Inc., 15-4524 (D.N.J.) June 26, 2015 Hon. Renee Marie Bumb Mucinex® D (guaifenesin / pseudoephedrine hydrochloride extended-release tablets)
6,372,252
6,955,821
7,838,032
Jazz Pharms., Inc. v. Watson Labs., Inc., 15-4532 (D.N.J.) June 26, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
8,859,619
8,952,062
Salix Pharms., Inc. v. Mylan Pharms., Inc., 15-0109 (N.D.W.V.) June 26, 2015 Hon. Irene M. Keeley Apriso® (mesalamine extended-release capsules)
6,551,620
8,337,886
8,496,965
8,865,688
Panacea Biotec Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01492 (PTAB) June 26, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,569,325
Panacea Biotec Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01496 (PTAB) June 26, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,404,703
Gilead Sciences, Inc. v. Sigmapharm Labs., LLC, 15-4898 (D.N.J.) June 30, 2015 Hon. Renee Marie Bumb Letairis® (ambrisentan tablets) RE42,462
Horizon Pharma Ireland Ltd. v. Taro Pharms. USA, Inc., 15-5021 (D.N.J.) June 30, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,066,913
Horizon Pharma Ireland Ltd. v. IGI Pharms., Inc., 15-5022 (D.N.J.) June 30, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,066,913
Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-5024 (D.N.J.) June 30, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,066,913
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 15-5025 (D.N.J.) June 30, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,066,913
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-5027 (D.N.J.) June 30, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,066,913

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.